Dataset Information

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.

ABSTRACT: Genetic mutations lead to the production of mutated proteins from which peptides are presented to T cells as cancer neoantigens. Evidence suggests that T cells that target neoantigens are the main mediators of effective cancer immunotherapies. Although algorithms have been used to predict neoantigens, only a minority are immunogenic. The factors that influence neoantigen immunogenicity are not completely understood. Here, we classified human neoantigen/neopeptide data into three categories based on their TCR-pMHC binding events. We observed a conservative mutant orientation of the anchor residue from immunogenic neoantigens which we termed the "NP" rule. By integrating this rule with an existing prediction algorithm, we found improved performance in neoantigen prioritization. To better understand this rule, we solved several neoantigen/MHC structures. These structures showed that neoantigens that follow this rule not only increase peptide-MHC binding affinity but also create new TCR-binding features. These molecular insights highlight the value of immune-based classification in neoantigen studies and may enable the design of more effective cancer immunotherapies.

SUBMITTER: Bai P

PROVIDER: S-EPMC7833777 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.

Bai Peng P Li Yongzheng Y Zhou Qiuping Q Xia Jiaqi J Wei Peng-Cheng PC Deng Hexiang H Wu Min M Chan Sanny K SK Kappler John W JW Zhou Yu Y Tran Eric E Marrack Philippa P Yin Lei L

Oncoimmunology 20210115 1

Genetic mutations lead to the production of mutated proteins from which peptides are presented to T cells as cancer neoantigens. Evidence suggests that T cells that target neoantigens are the main mediators of effective cancer immunotherapies. Although algorithms have been used to predict neoantigens, only a minority are immunogenic. The factors that influence neoantigen immunogenicity are not completely understood. Here, we classified human neoantigen/neopeptide data into three categories based ...[more]

PMID: 33537173

Similar Datasets

Project description:BackgroundReliable prediction of stability changes in protein variants is an important aspect of computational protein design. A number of machine learning methods that allow a classification of stability changes knowing only the sequence of the protein emerged. However, their performance on amino acid substitutions of previously unseen non-homologous proteins is rather limited. Moreover, the performance varies for different types of mutations based on the secondary structure or accessible surface area of the mutation site.ResultsWe proposed feature-based multiple models with each model designed for a specific type of mutations. The new method is composed of five models trained for mutations in exposed, buried, helical, sheet, and coil residues. The classification of a mutation as stabilising or destabilising is made as a consensus of two models, one selected based on the predicted accessible surface area and the other based on the predicted secondary structure of the mutation site. We refer to our new method as Evolutionary, Amino acid, and Structural Encodings with Multiple Models (EASE-MM). Cross-validation results show that EASE-MM provides a notable improvement to our previous work reaching a Matthews correlation coefficient of 0.44. EASE-MM was able to correctly classify 73% and 75% of stabilising and destabilising protein variants, respectively. Using an independent test set of 238 mutations, we confirmed our results in a comparison with related work.ConclusionsEASE-MM not only outperformed other related methods but achieved more balanced results for different types of mutations based on the accessible surface area, secondary structure, or magnitude of stability changes. This can be attributed to using multiple models with the most relevant features selected for the given type of mutations. Therefore, our results support the presumption that different interactions govern stability changes in the exposed and buried residues or in residues with a different secondary structure.

Dataset Information

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.

Publications

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets